Article | February 20, 2025
Article | February 19, 2025
FDA Layoffs, RFK Jr. at HHS, and More Including What This Means for FDA-Regulated Companies
Read More
Article | February 11, 2025
SIUU Final Guidance: Opportunities for Proactive Scientific Messaging
Read More
Article | January 21, 2025
Sunshine Act Compliance: How to Take Action to Meet Reporting Requirements and Avoid Costly Penalties
Read More
Article | January 16, 2025
FDA Bans Red Dye No. 3: What Food and Drug Manufacturers Need to Know
Read More
Article | January 14, 2025
Streamlining Device Changes with Predetermined Change Control Plans (PCCPs)
Read More
Article | December 20, 2024
Due Diligence Decoded: Insights from In-House Counsel at Boston Program
Read More
Article | December 19, 2024
Exploring the Loper Decision: Impacts on FDA-Regulated Transactions
Read More
Article | December 17, 2024
Honesty is the Best Policy: Navigating the DOJ’s M&A Safe Harbor
Read More
Article | December 15, 2024
Navigating the Complex Regulatory Landscape for AI/ML-Enabled Medical Devices
Read More
Article | November 21, 2024
Post-Election FDA Landscape: Will There Be Regulatory Shifts Ahead in 2025 and Beyond?
Read More
